Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | cathepsin b | 0.0166 | 1 | 1 |
Brugia malayi | Matrixin family protein | 0.0038 | 0.1909 | 0.1909 |
Giardia lamblia | Cathepsin B precursor | 0.0055 | 0.2985 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0055 | 0.2985 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1909 | 0.1909 |
Giardia lamblia | Cathepsin B precursor | 0.0055 | 0.2985 | 0.5 |
Giardia lamblia | Cathepsin B precursor | 0.0055 | 0.2985 | 0.5 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0166 | 1 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0166 | 1 | 1 |
Mycobacterium ulcerans | hydrolase | 0.0046 | 0.2428 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1909 | 0.1909 |
Brugia malayi | Matrixin family protein | 0.0038 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 1 | 1 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0046 | 0.2428 | 0.5 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0055 | 0.2985 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0091 | 0.5283 | 0.5283 |
Onchocerca volvulus | Matrilysin homolog | 0.0084 | 0.4807 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0084 | 0.4807 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0166 | 1 | 1 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0038 | 0.1909 | 0.1909 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0055 | 0.2985 | 0.2985 |
Brugia malayi | Matrixin family protein | 0.0038 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | matrixin family protein | 0.0084 | 0.4807 | 0.4807 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0007 | 0.00000011673 | 0.00000011673 |
Echinococcus multilocularis | cathepsin b | 0.0166 | 1 | 1 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0137 | 0.8181 | 0.8181 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0166 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.2903 | 0.2903 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0046 | 0.2428 | 0.2428 |
Brugia malayi | Hemopexin family protein | 0.0053 | 0.2903 | 0.2903 |
Echinococcus granulosus | cathepsin b | 0.0166 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0166 | 1 | 1 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0166 | 1 | 1 |
Onchocerca volvulus | 0.0053 | 0.2903 | 0.3431 | |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0137 | 0.8181 | 0.8181 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0055 | 0.2985 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.1909 | 0.1909 |
Brugia malayi | Matrixin family protein | 0.0038 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | matrixin family protein | 0.0091 | 0.5283 | 0.5283 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.009 | 0.5181 | 0.5181 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0007 | 0.00000011673 | 0.00000011673 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0007 | 0.00000011673 | 0.00000011673 |
Toxoplasma gondii | cathepsin B | 0.0055 | 0.2985 | 0.5 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0046 | 0.2428 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2428 | 0.2428 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0038 | 0.1909 | 0.1909 |
Loa Loa (eye worm) | cathepsin B | 0.0055 | 0.2985 | 0.2985 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 25 uM | Inhibition of bovine spleen cathepsin B using Z-Arg-Arg-AMC as substrate after 30 mins by fluorescence assay | ChEMBL. | 24960234 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.